Cambridge Antibody Technology announced last week the retirement of chief medical officer David Glover from the company and the board after the company’s annual general meeting on Feb. 4. Following Glover’s retirement, Patrick Round, vice president for development at CAT, will join the company’s executive group which has responsibility for the operational management of CAT.
In addition, Diane Mellett, general counsel and company secretary at CAT, will join CAT’s board of directors following the Feb. 4 meeting.